Direxion Daily S&P Biotech Bull 3x Shares Rating $61.64 +2.24 (+3.77%) Closing price 05/2/2025 04:10 PM EasternExtended Trading$61.75 +0.11 (+0.18%) As of 05/2/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.76Holdings in LABU have an aggregate rating of Moderate Buy based on 705 analyst ratings issued in the past year covering 45 companies (49.0% of the portfolio).LABU Aggregate Price Target$61.64High Prediction$61.64Average Prediction$61.64Low Prediction$61.64Holdings in LABU have an aggregate price target of $61.64 and a range of $61.64 to $61.64 covering 45 companies (49.0% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.86%NTRANatera$156.66+3.5%2.8931 of 5 stars3.00$175.76 12.2%16Upcoming EarningsInsider TradePositive News1.79%VRTXVertex Pharmaceuticals$501.15+0.5%3.9685 of 5 stars2.64$514.91 2.7%25Upcoming EarningsPositive News1.78%INSMInsmed$72.30-0.5%4.3778 of 5 stars3.00$94.00 30.0%16Upcoming EarningsInsider TradeNews CoveragePositive News1.76%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.216 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews CoveragePositive News1.69%NBIXNeurocrine Biosciences$109.68+2.9%4.8844 of 5 stars2.86$160.90 46.7%22Upcoming Earnings1.68%UTHRUnited Therapeutics$294.60+0.3%4.9871 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst ForecastInsider TradePositive News1.66%GILDGilead Sciences$103.68+0.4%4.7892 of 5 stars2.78$110.55 6.6%27Dividend Announcement1.63%EXASExact Sciences$51.55+9.3%4.5147 of 5 stars2.95$70.90 37.5%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap UpHigh Trading Volume1.61%AMGNAmgen$281.22-0.9%4.095 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Up1.56%INCYIncyte$62.53+0.8%4.7861 of 5 stars2.17$73.53 17.6%18Earnings ReportAnalyst ForecastAnalyst Revision1.54%BIIBBiogen$123.53+2.2%4.7064 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.52%MDGLMadrigal Pharmaceuticals$315.48-3.7%4.6031 of 5 stars2.90$416.33 32.0%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.48%ABBVAbbVie$198.62+2.7%4.6115 of 5 stars2.89$211.41 6.4%27Earnings ReportAnalyst ForecastAnalyst Revision1.48%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8364 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.41%BPMCBlueprint Medicines$104.64+5.4%1.7614 of 5 stars2.76$127.22 21.6%21Earnings ReportAnalyst ForecastNews CoveragePositive News1.40%EXELExelixis$39.60+1.8%4 of 5 stars2.47$37.59 -5.1%19Short Interest ↑Analyst RevisionPositive News1.30%BMRNBioMarin Pharmaceutical$62.03-1.1%4.9217 of 5 stars2.70$92.95 49.9%23Analyst ForecastAnalyst RevisionNews CoverageGap Up1.28%MRNAModerna$27.61+2.1%4.3397 of 5 stars2.04$53.95 95.4%23Earnings ReportAnalyst ForecastNews Coverage1.17%TGTXTG Therapeutics$43.44-4.3%3.3297 of 5 stars2.80$40.80 -6.1%5News CoveragePositive News1.15%BBIOBridgeBio Pharma$38.57+0.4%4.6172 of 5 stars2.92$57.09 48.0%12Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.10%HALOHalozyme Therapeutics$61.19+1.9%4.1257 of 5 stars2.60$62.89 2.8%10Upcoming EarningsAnalyst RevisionNews Coverage1.01%RVMDRevolution Medicines$40.72+0.2%3.7686 of 5 stars3.00$66.67 63.7%12Upcoming EarningsPositive News0.98%CYTKCytokinetics$37.35-13.0%4.0604 of 5 stars2.89$76.88 105.8%19Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownHigh Trading Volume0.95%SMMTSummit Therapeutics$27.90+13.1%2.9037 of 5 stars3.00$37.40 34.1%10Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up0.93%CRSPCRISPR Therapeutics$38.25+1.4%3.0161 of 5 stars2.48$73.11 91.1%21Upcoming Earnings0.88%SRPTSarepta Therapeutics$63.51+1.2%4.7181 of 5 stars2.83$157.95 148.7%23Upcoming Earnings0.84%ROIVRoivant Sciences$11.48-0.9%2.2495 of 5 stars3.00$17.50 52.4%4Positive News0.84%IONSIonis Pharmaceuticals$32.78+3.4%4.3991 of 5 stars2.65$56.67 72.9%20Earnings ReportAnalyst ForecastInsider TradeNews Coverage0.80%ADMAADMA Biologics$23.52+1.1%1.479 of 5 stars3.25$22.50 -4.3%4Upcoming EarningsOptions VolumeNews CoveragePositive NewsGap Up0.74%VKTXViking Therapeutics$29.36+2.6%4.5291 of 5 stars3.00$87.15 196.8%14Analyst UpgradeOptions VolumeAnalyst RevisionGap Up0.71%SWTXSpringWorks Therapeutics$46.23+0.0%2.1428 of 5 stars2.13$52.57 13.7%8Analyst ForecastNews CoverageHigh Trading Volume0.68%ALKSAlkermes$31.78+3.9%4.1804 of 5 stars2.67$38.33 20.6%12Earnings ReportAnalyst ForecastNews Coverage0.68%KRYSKrystal Biotech$166.16+0.3%4.9093 of 5 stars3.00$222.71 34.0%8Upcoming EarningsAnalyst RevisionNews Coverage0.68%PCVXVaxcyte$35.39+0.4%2.9051 of 5 stars3.10$136.50 285.7%10Upcoming EarningsNews CoveragePositive News0.65%RNAAvidity Biosciences$32.20-1.5%2.7117 of 5 stars3.00$66.69 107.1%13Upcoming EarningsInsider TradePositive News0.62%NUVLNuvalent$77.46+1.6%1.9383 of 5 stars2.90$115.50 49.1%10Upcoming EarningsNews CoveragePositive News0.61%TWSTTwist Bioscience$39.24+4.1%3.6508 of 5 stars2.70$52.80 34.6%10Upcoming EarningsNews CoveragePositive News0.61%ACLXArcellx$65.55+0.0%1.8674 of 5 stars3.14$110.67 68.8%14Upcoming EarningsNews CoveragePositive News0.60%RYTMRhythm Pharmaceuticals$64.01+0.3%3.7807 of 5 stars3.00$74.92 17.0%13Upcoming EarningsInsider Trade0.58%VCYTVeracyte$30.35+2.2%4.0411 of 5 stars2.70$42.60 40.4%10Upcoming EarningsShort Interest ↑High Trading Volume0.58%SRRKScholar Rock$32.91+0.5%4.0698 of 5 stars3.00$42.67 29.6%6Upcoming EarningsInsider TradeNews CoveragePositive News0.55%APLSApellis Pharmaceuticals$20.34+1.3%4.2447 of 5 stars2.65$45.28 122.6%20Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage0.55%RXRXRecursion Pharmaceuticals$5.70+3.6%2.3051 of 5 stars2.33$8.20 43.9%6Upcoming EarningsGap Up0.54%SLNOSoleno Therapeutics$75.23+0.3%4.672 of 5 stars3.20$104.67 39.1%10Upcoming EarningsNews CoveragePositive News0.53%RAREUltragenyx Pharmaceutical$39.30+0.8%4.3727 of 5 stars2.93$92.79 136.1%14Upcoming EarningsShort Interest ↑Positive News This page (NYSEARCA:LABU) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LABU Stock Free LABU Stock Alerts